España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
iRadimed
IRMD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$54.65
1.30
2.44%
At close: -
$54.65
0.00
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
iRadimed (IRMD) Forecast
News
Earnings
iRadimed (IRMD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for iRadimed (NASDAQ:IRMD) Stock
iRadimed Stock (NASDAQ: IRMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 03, 2024
iRadimed Chief Financial Officer Sold $135K In Company Stock
Benzinga Insights
Thursday, October 31, 2024
IRadimed Raised FY24 Adj EPS To $1.64 -$1.67 From $1.52 -$1.62 (Vs $1.56 Est.); Revenue To $72.7M-$73.1M From $$72M-$74M Vs $72.62M Est.
Lekha Gupta
IRadimed Sees Q4 EPS $0.42-$0.45 Vs $0.39 Est...
Lekha Gupta
iRadimed Q3 2024 Adj. EPS $0.43 Beats $0.39 E...
Benzinga Newsdesk
Thursday, October 10, 2024
Future Forward: 7 Groundbreaking Healthcare Technology Companies Poised To Disrupt the Industry By 2025
Tanvir Zafar
Friday, August 02, 2024
Roth MKM Maintains Buy on iRadimed, Lowers Pr...
Benzinga Newsdesk
Thursday, August 01, 2024
IRadimed Sees Q3 EPS $0.38-$0.41 Vs $0.37 Est...
Benzinga Newsdesk
iRadimed Q2 2024 Adj. EPS $0.42 Beats $0.36 E...
Benzinga Newsdesk
Friday, June 07, 2024
IRadimed Announces Uplisting To The Nasdaq Gl...
Benzinga Newsdesk
Thursday, May 02, 2024
IRADIMED Expects Q2 Adjusted EPS Of $1.52-$1....
Benzinga Newsdesk
IRADIMED Expects 2024 Revenues Of $72M-$74M V...
Benzinga Newsdesk
IRADIMED Expects Q2 Adjusted EPS Of $0.36 to ...
Benzinga Newsdesk
IRADIMED Expects Q2 Revenues Of $17.6M-$17.8M...
Benzinga Newsdesk
iRadimed Q1 2024 Adj EPS $0.36 Beats $0.34 Es...
Benzinga Newsdesk
Monday, April 22, 2024
Roth MKM Reinstates Buy on iRadimed, Announce...
Benzinga Newsdesk
Wednesday, April 03, 2024
Iradimed Corp Files For Offering Of Common St...
Benzinga Newsdesk
Thursday, February 08, 2024
IRadimed Forecasts FY24 Revenue of $72M-$74M,...
Benzinga Newsdesk
IRadimed Forecasts Q1 FY24 Revenue of $17M-$1...
Benzinga Newsdesk
iRadimed Q4 Adjusted EPS $0.39 Misses $0.40 E...
Benzinga Newsdesk
Earnings Scheduled For February 8, 2024
Benzinga Insights
Wednesday, February 07, 2024
iRadimed's Earnings Outlook
Benzinga Insights
Tuesday, January 09, 2024
IRADIMED CORPORATION Reports Unaudited Q4 Rev...
Benzinga Newsdesk
Monday, December 18, 2023
Wednesday Is Your Last Chance To Buy iRadimed Before The Dividend Payout
Benzinga Insights
Friday, November 03, 2023
IRADIMED shares are trading higher after the ...
Benzinga Newsdesk
IRADIMED Sees FY23 Adjusted EPS Of $1.48-$1.5...
Benzinga Newsdesk
IRADIMED Sees FY23 Revenue Of $65.0M-$65.5M V...
Benzinga Newsdesk
IRADIMED Sees Q4 FY23 Adjusted EPS Of $0.38-$...
Benzinga Newsdesk
IRADIMED Sees Q4 FY23 Revenue Of $16.9M-$17.4...
Benzinga Newsdesk
iRadimed Q3 Adjusted EPS $0.43 Beats $0.36 Es...
Benzinga Newsdesk
Earnings Scheduled For November 3, 2023
Benzinga Insights
Thursday, November 02, 2023
iRadimed's Earnings: A Preview
Benzinga Insights
Friday, October 13, 2023
Caleres, Cloudflare And 2 Other Stocks Insiders Are Selling
Lisa Levin
Thursday, August 03, 2023
IRadimed Corporation shares are trading highe...
Benzinga Newsdesk
IRadimed Expects FY23 Revenue Of $64.5M-$65.5...
Benzinga Newsdesk
IRadimed Expects Q3 FY23 Revenue Of $16.1M-$1...
Benzinga Newsdesk
iRadimed Q2 Adjusted EPS $0.36 Beats $0.31 Es...
Benzinga Newsdesk
Earnings Scheduled For August 3, 2023
Benzinga Insights
Thursday, June 08, 2023
Massive Insider Trade At iRadimed
Benzinga Insights
Tuesday, May 09, 2023
iRadimed President Sold $461K In Company Stock
Benzinga Insights
Thursday, May 04, 2023
iRadimed: Q1 Earnings Insights
Benzinga Insights
iRadimed Boosts FY23 Revenue Guidance From $6...
Benzinga Newsdesk
iRadimed Expects Q2 Revenue Of $15.6M-$15.8M ...
Benzinga Newsdesk
iRadimed Q1 Adj EPS $0.30 Beats $0.28 Estimat...
Benzinga Newsdesk
Earnings Scheduled For May 4, 2023
Benzinga Insights
Wednesday, May 03, 2023
iRadimed's Earnings: A Preview
Benzinga Insights
Monday, February 27, 2023
Iradimed Notifies Potential Issue With Certain Syringe Adapter Sets During Use
Vandana Singh
Friday, February 24, 2023
IRadimed Issues Urgent Medical Device Correct...
Michael Horton
Thursday, February 02, 2023
IRADIMED Expects FY23 Adjusted EPS Of $1.23-$...
Benzinga Newsdesk
IRADIMED's Board Has Approved Special Cash Di...
Benzinga Newsdesk
iRadimed Q4 Adjusted EPS $0.32 Beats $0.30 Es...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch